Drug Type Biological products |
Synonyms CLF 065, CLF065 |
Target |
Action agonists |
Mechanism GLP-2R agonists(Glucagon-like peptide 2 receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Pouchitis | Phase 2 | - | 01 Nov 2025 | |
| Inflammatory Bowel Diseases | Phase 1 | - | - |





